Evolent Health Osake

Evolent Health EV/FCF

EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) yhtiöstä Evolent Health (EVH) 16.8.2026 päivämäärällä on 33,55. Edellisenä vuonna EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) oli −132,16 — muutos −125,38 % (korkeampi).

EV/FCF

33,55

YoY

−125,38%

Viimeksi päivitetty:

EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) yhtiöstä Evolent Health on 2026 33,55 . EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) yhtiöstä Evolent Health oli 2025 −132,16 . Se laskee −125,38% korkeampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

Evolent Health Osakeanalyysi

Mitä Evolent Health tekee? Evolent Health Inc was founded in 2011 and is a healthcare services company based in Arlington, VA USA. The company was founded by a group of CEOs and executives to revolutionize the healthcare system and reduce healthcare costs in the US. Evolent, a wordplay on "evolution" and "diligent," is committed to improving healthcare services through innovative ideas and technologies. Over the years, Evolent Health's business model has evolved and expanded to meet the needs of a wide range of healthcare organizations and their patients. The company works with healthcare organizations such as hospitals, medical centers, health plans, and physicians to provide effective and affordable healthcare solutions. Evolent Health offers various services tailored to the needs of different healthcare organizations. One of their core competencies is the development and implementation of population health management programs. These programs aim to improve patient health while reducing costs. The company also offers technology platforms that healthcare organizations can use to manage data, improve treatment outcomes, and facilitate communication between doctors and patients. Another important aspect of Evolent Health is the care of Medicare and Medicaid patients. The company works with health plans to provide better healthcare services to these underserved populations. Evolent Health also offers specialized services, such as the treatment of patients with chronic conditions like diabetes or cardiovascular diseases. In recent years, Evolent Health has also expanded its portfolio through acquisitions and partnerships. In 2018, two acquisitions were completed, namely Valence Health and New Century Health. These acquisitions have strengthened Evolent Health's position in the field of population health management programs and specialized services for cancer patients. Another innovative product of Evolent Health is the Virtual Health Center. This program offers virtual consultations and treatments for patients who cannot make in-person visits to doctors due to distance or busy lifestyles. The program utilizes state-of-the-art telemedicine technology to provide patients with high-quality medical care while allowing them to stay comfortably at home. Evolent Health has an impressive track record in improving patient outcomes and reducing healthcare costs. In 2020, the company received the highest rating in the "Population Health Management" category of the Healthcare Informatics 100 Rankings. The company serves nearly 3 million patients in the US and operates in over 30 states. Overall, the company has the potential to change the healthcare system in the US and beyond through its vision, innovation, and commitment to high-quality healthcare services. Evolent's focus on improving healthcare delivery and reducing costs has the potential to be a role model for the entire industry. Evolent Health on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Evolent Health osakkeesta

Yhtiön Evolent Health EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) on 33,55 vuonna 2026.

EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) yhtiöstä Evolent Health muuttui arvosta −132,16 arvoon 33,55, mikä edustaa −125,38 % muutosta. Arvo on korkeampi kuin edellisenä vuonna.

Eurpoolissa voit löytää EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) Evolent Health:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

EV/FCF-suhde mittaa yrityksen arvoa suhteessa vapaaseen kassavirtaan. Se heijastaa yrityksen todellista kassantuottokykyä.

Arvioidakseen EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan):n, on olennaista verrata sitä saman alan ja sektorin kilpailijoihin. Eulerpoolissa voit löytää suoria alan vertailuja EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan):lle.

"Hyvä" vaihtelee alan ja yrityksen kehitysvaiheen mukaan. Eulerpoolissa voit verrata EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan):n Evolent Health alan vertaisiin ja alan keskiarvoon arvioidaksesi houkuttelevuuden.

Access this data via the Eulerpool API

Arvostus — Evolent Health

Kaikki tunnusluvut — Evolent Health